• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度一所大学医院内疫苗接种后 COVID-19 的严重程度和结局。

Severity and Outcome of Post-Vaccine COVID-19 among Healthcare Workers in a University Hospital in India.

机构信息

Department of Medicine, Pacific Medical College and Hospital, Pacific Medical University, Udaipur, Rajasthan, India.

Department of Pediatrics, Pacific Medical College and Hospital, Pacific Medical University, Udaipur, Rajasthan, India.

出版信息

J Med Life. 2023 May;16(5):782-793. doi: 10.25122/jml-2023-0017.

DOI:10.25122/jml-2023-0017
PMID:37520491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10375337/
Abstract

Healthcare workers (HCWs) are at high risk of COVID-19 infection despite vaccination. Limited data exist on COVID-19 cases among vaccinated HCWs. This study aimed to describe the clinical characteristics and outcomes of RT PCR-confirmed COVID-19 cases in vaccinated HCWs, at a COVID clinic in a medical college hospital. This single-center, prospective cohort study included HCWs who received at least one dose of the COVID-19 vaccine and tested positive for COVID-19 within 6 months. Data on demographics, symptoms, work category, COVID-19 vaccination interval, and infection severity were collected. Of 2381 vaccinated HCWs, 105 tested positive and were categorized as mild, moderate, or severe cases. Among vaccinated HCWs, 4.41% had post-vaccine COVID-19 infections. All 105 cases received the first dose, and 79 received the second dose. Of the cases, 47.6% were partially vaccinated, and 53.3% were breakthrough cases. The mean age was 30.90±8.69 years, with 63.8% male and 36.2% female cases. Most cases (85.7%) acquired infection in the hospital, and 47.6% had direct contact with COVID-19 patients. Common symptoms included fatigue (85.7%), fever (82.9%), and cough (64.8%). Among cases, 93.3% were mild, 5.7% were moderate, and 0.9% were severe. Hospital admission and supplemental oxygen therapy were required for moderate and severe cases. No mortality was reported. Certain variables were associated with age, preventive measures, workplace type, symptoms, and comorbidities. Breakthrough infections can occur among fully vaccinated HCWs but with reduced severity and mortality. Monitoring and infection control measures remain crucial even in vaccinated individuals. This study provides insights into clinical presentations, oxygen therapy requirements, and outcomes of post-vaccine COVID-19 cases among HCWs. The data will inform strategies for booster doses to prevent COVID-19.

摘要

医护人员(HCWs)尽管已接种疫苗,但仍面临 COVID-19 感染的高风险。关于接种疫苗的 HCWs 中 COVID-19 病例的数据有限。本研究旨在描述医学院附属医院 COVID 诊所接种 COVID-19 疫苗的 HCWs 中经 RT-PCR 确诊的 COVID-19 病例的临床特征和结局。这是一项单中心前瞻性队列研究,纳入了至少接种一剂 COVID-19 疫苗且在 6 个月内 COVID-19 检测呈阳性的 HCWs。收集了人口统计学、症状、工作类别、COVID-19 疫苗接种间隔和感染严重程度的数据。在 2381 名接种疫苗的 HCWs 中,有 105 人检测呈阳性,并分为轻症、中症或重症病例。在接种疫苗的 HCWs 中,4.41%发生了疫苗接种后 COVID-19 感染。所有 105 例均接种了第一剂,79 例接种了第二剂。其中,47.6%为部分接种,53.3%为突破性病例。病例的平均年龄为 30.90±8.69 岁,男性占 63.8%,女性占 36.2%。大多数病例(85.7%)在医院感染,47.6%有与 COVID-19 患者的直接接触。常见症状包括疲劳(85.7%)、发热(82.9%)和咳嗽(64.8%)。病例中,93.3%为轻症,5.7%为中症,0.9%为重症。中症和重症病例需要住院和补充氧气治疗。无死亡报告。某些变量与年龄、预防措施、工作场所类型、症状和合并症有关。突破性感染可发生在完全接种疫苗的 HCWs 中,但严重程度和死亡率降低。即使在接种疫苗的个体中,监测和感染控制措施仍然至关重要。本研究提供了接种疫苗后 COVID-19 病例在 HCWs 中的临床表现、氧气治疗需求和结局的见解。这些数据将为预防 COVID-19 的加强针策略提供信息。

相似文献

1
Severity and Outcome of Post-Vaccine COVID-19 among Healthcare Workers in a University Hospital in India.印度一所大学医院内疫苗接种后 COVID-19 的严重程度和结局。
J Med Life. 2023 May;16(5):782-793. doi: 10.25122/jml-2023-0017.
2
Breakthrough covid 19 infections after 2 doses of covid 19 vaccination and comparing severity between hospitalized and non hospitalized in tertiary care hospital.突破性感染 COVID-19 后接种 2 剂 COVID-19 疫苗,并比较三级保健医院住院和非住院患者的严重程度。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
3
COVID-19 vaccine breakthrough infection among health care workers at MODHS hospitals in Saudi Arabia: A multicenter study.沙特阿拉伯 MODHS 医院医护人员中的 COVID-19 疫苗突破性感染:一项多中心研究。
J Infect Public Health. 2024 Jun;17(6):1117-1124. doi: 10.1016/j.jiph.2024.04.021. Epub 2024 Apr 26.
4
Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).的里雅斯特教学医院(意大利东北部)医护人员中新冠病毒疫苗突破性感染的风险及相关因素
Viruses. 2022 Feb 7;14(2):336. doi: 10.3390/v14020336.
5
Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).与接种灭活 SARS-CoV2 疫苗(科兴疫苗)的医护人员疫苗突破性感染发生率相关的因素。
J Res Health Sci. 2022 Jun 30;22(2):e00551. doi: 10.34172/jrhs.2022.86.
6
COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study.在伊拉克库尔德地区杜胡克省,完全接种疫苗的医护人员中 COVID-19 疫苗突破性感染:一项回顾性队列研究。
J Med Virol. 2022 Nov;94(11):5244-5250. doi: 10.1002/jmv.27985. Epub 2022 Jul 26.
7
SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.印度新德里卫生保健工作者中 SARS-CoV-2 再感染率和 BBV152 灭活全病毒疫苗预防再感染的估计效力。
JAMA Netw Open. 2022 Jan 4;5(1):e2142210. doi: 10.1001/jamanetworkopen.2021.42210.
8
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.印度孟买医护人员中新冠疫苗(CovishieldTM 和 Covaxin ®)的有效性:一项回顾性队列分析。
PLoS One. 2022 Oct 27;17(10):e0276759. doi: 10.1371/journal.pone.0276759. eCollection 2022.
9
SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study.医护人员接种 COVID-19 疫苗后感染 SARS-CoV-2:一项回顾性、试点研究。
Indian J Med Res. 2021;153(5&6):550-554. doi: 10.4103/ijmr.ijmr_1485_21.
10
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.2021 年 12 月 1 日至 2022 年 5 月 31 日,在意大利东北部的的里雅斯特和戈里齐亚的医护人员中,奥密克戎传播期间的 SARS-CoV-2 初次感染、再感染和疫苗有效性。
Viruses. 2022 Nov 30;14(12):2688. doi: 10.3390/v14122688.

引用本文的文献

1
The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?新冠疫苗第三剂的有效性:何时应接种?
Vaccines (Basel). 2024 Mar 16;12(3):315. doi: 10.3390/vaccines12030315.

本文引用的文献

1
SARS-CoV-2 Breakthrough Infections in Health Care Workers: An Italian Retrospective Cohort Study on Characteristics, Clinical Course and Outcomes.医护人员中新型冠状病毒2型突破性感染:一项关于特征、临床病程及结局的意大利回顾性队列研究
J Clin Med. 2023 Jan 12;12(2):628. doi: 10.3390/jcm12020628.
2
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers.严重急性呼吸综合征冠状病毒2突破性感染:欧洲大型多中心医护人员队列中的发病率及风险因素
Vaccines (Basel). 2022 Jul 27;10(8):1193. doi: 10.3390/vaccines10081193.
3
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
医护人员完成 COVID-19 疫苗接种与 SARS-CoV-2 感染之间的时间延迟。
Vaccine. 2022 May 20;40(23):3159-3164. doi: 10.1016/j.vaccine.2022.04.045. Epub 2022 Apr 18.
4
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染和 COVID-19 疾病有效性的持续时间:系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.
5
Impact of COVID-19 pandemic on healthcare workers.新冠疫情对医护人员的影响。
Ind Psychiatry J. 2021 Oct;30(Suppl 1):S282-S284. doi: 10.4103/0972-6748.328830. Epub 2021 Oct 22.
6
Characteristic Features of COVID-19 Illness Among Healthcare Workers: A Retrospective Analysis.医护人员中新冠肺炎疾病的特征:一项回顾性分析。
Cureus. 2021 Oct 16;13(10):e18816. doi: 10.7759/cureus.18816. eCollection 2021 Oct.
7
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性:一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
8
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.接种 BNT162b2 疫苗和加强针后,Delta 变异株 SARS-CoV-2 突破感染的病毒载量。
Nat Med. 2021 Dec;27(12):2108-2110. doi: 10.1038/s41591-021-01575-4. Epub 2021 Nov 2.
9
COVID vaccine immunity is waning - how much does that matter?新冠疫苗的免疫力正在减弱——这有多重要?
Nature. 2021 Sep;597(7878):606-607. doi: 10.1038/d41586-021-02532-4.
10
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.辉瑞-BioNTech 疫苗加强针在以色列预防新冠病毒。
N Engl J Med. 2021 Oct 7;385(15):1393-1400. doi: 10.1056/NEJMoa2114255. Epub 2021 Sep 15.